Over the past decade, BC Cancer has delivered world first discoveries in breast cancer that have transformed the way the disease is treated today. They are global leaders in producing landmark publications and are the most widely cited research group in the world on breast cancer.

The team discovered 10 unique sub-types of breast cancer, decoding the genomic structure of the most deadly of these, and proving that cancer has the ability to change over time and in response to treatments.

Now, they’ve launched B-PRECISE. The key focus is tackling unmet medical needs and bringing precision medicine to patients, in particular those with rare and hard to treat sub-types.

The Goals Of B-PRECISE Are:

• to better understand how tumours evolve
• to learn how to treat them most effectively
• to learn how to prevent cancer from returning, and
• to learn how to identify patients at high-risk who may require more intensive therapies.

B-PRECISE will answer the toughest questions plaguing breast cancer researchers and clinicians to find better solutions for patients.